Dmytro Kharkov

Emergent Biosolutions calls for combining strategic stockpiling and surge manufacturing to boost preparedness

Emergent Biosolutions calls for combining strategic stockpiling and surge manufacturing to boost preparedness
Emergent Biosolutions urges dual strategy

Emergent Biosolutions urges that true preparedness against intensifying global biological threats requires more than just stockpiling resources.

The company advocates for a dual strategy that integrates both strategic stockpiling and the capacity for surge manufacturing, as outlined in its latest white paper. This approach is intended to enhance resilience by ensuring that nations and organizations can respond rapidly and effectively at scale during biological emergencies. Emergent Biosolutions emphasizes that adopting such comprehensive measures is vital for keeping pace with evolving threats in the current landscape.

Emergent Biosolutions has previously highlighted its core mission to protect Americans through preparedness efforts against biological threats, as detailed in an earlier statement. The company has also supported initiatives abroad, backing the launch of a MpOx study in Madagascar in response to a local outbreak, with the first patient enrolled. These actions follow continued attention on both domestic and international biological safety.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.